BLB(SZ:002286)2014-08-05 16:00Financial Performance - The company's operating revenue for the first half of 2014 was CNY 450,900,434.47, representing a 16.01% increase compared to CNY 388,679,178.90 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was CNY 26,256,298.04, a slight increase of 1.06% from CNY 25,981,592.70 year-on-year[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 22,319,849.55, up 2.13% from CNY 21,853,684.67 in the previous year[21]. - Basic earnings per share decreased by 22.22% to CNY 0.07 from CNY 0.09 in the previous year[21]. - Diluted earnings per share also fell by 14.29% to CNY 0.06 from CNY 0.07 year-on-year[21]. - The weighted average return on net assets was 1.81%, down from 2.52% in the previous year, a decrease of 0.71%[21]. - The company achieved a revenue of 450.90 million yuan in the first half of 2014, representing a year-on-year growth of 16.01%[30]. - The net profit for the same period was 26.26 million yuan, showing a slight increase of 1.06% compared to the previous year[30]. Cash Flow and Assets - The net cash flow from operating activities was negative at CNY -12,755,845.84, a significant decrease of 145.79% compared to CNY 27,859,061.42 in the same period last year[21]. - Total assets at the end of the reporting period were CNY 1,669,939,753.68, a decrease of 0.37% from CNY 1,676,213,763.73 at the end of the previous year[21]. - Current assets decreased from CNY 797,856,787.97 to CNY 710,683,811.81, reflecting a decline of approximately 10.9%[126]. - Cash and cash equivalents decreased from CNY 361,316,011.12 to CNY 332,072,262.78, a reduction of about 8.1%[126]. - Inventory increased significantly from CNY 110,136,601.35 to CNY 164,501,837.26, representing an increase of approximately 49.3%[126]. - Non-current assets increased from CNY 878,356,975.76 to CNY 959,255,941.87, an increase of about 9.2%[127]. Liabilities and Equity - The total liabilities decreased by 9.67% year-on-year to 217.58 million yuan[31]. - Total liabilities decreased to CNY 210,296,153.55 from CNY 229,855,751.09 in the previous period, reflecting a reduction of 8.67%[131]. - The total equity attributable to the parent company at the end of the previous year was CNY 1,435,336,000.00[147]. - The total equity at the end of the current period increased to CNY 1,452,361,000.00, showing a growth from the previous year[152]. Business Operations and Growth - International business saw a significant growth of 95.71% during the reporting period[36]. - The company successfully expanded the application of its oligosaccharides feed additive to weaned piglets, enhancing its animal nutrition business[38]. - The company implemented advanced technologies, improving the effective ingredient content of oligosaccharides by over 20%[38]. - The company achieved a profit of 9.90 million yuan from the annual production of 10,000 tons of fructooligosaccharides, driven by a significant increase in market demand, particularly in the infant formula sector, although it remains below initial expectations[57]. - The company plans to focus on expanding its market presence and enhancing its product offerings in the upcoming quarters[144]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 20,569[113]. - Liu Zongli holds 25.01% of shares, totaling 92,368,640 shares[113]. - The total share capital increased from 184,628,000 shares to 369,256,000 shares through a capital reserve transfer of 10 shares for every 10 shares held[72]. - The company distributed a cash dividend of ¥0.50 per share and conducted a bonus share issue of 1:1 based on the total share capital as of December 31, 2013[110]. Governance and Compliance - The company has established and revised governance systems in compliance with relevant laws and regulations, enhancing its governance level[79]. - The financial report for the half-year was not audited[104]. - There were no significant litigation or arbitration matters during the reporting period[83]. - The company did not engage in any asset acquisitions, sales, or mergers during the reporting period[86][88]. Financial Management and Investments - The company is actively seeking opportunities for capital operation and financial development to enhance its business model[39]. - The company has committed to using part of the raised funds to temporarily supplement working capital, with a decision made on October 11, 2010, to allocate 35 million yuan for this purpose[57]. - The company has approved the use of RMB 300 million of idle raised funds to purchase principal-protected bank financial products, with an actual balance of RMB 100 million as of June 30, 2014[65]. - The company engaged in various entrusted financial management activities, with total amounts reaching ¥3.7 million and ¥6 million in different transactions[48]. Financial Reporting and Standards - The financial statements are prepared in accordance with the Chinese Accounting Standards, ensuring compliance and transparency[160]. - The company recognizes impairment losses for financial assets when there is objective evidence of impairment, with significant individual assets tested separately[195].